Abstract
In continuation of our program to find compounds with potent anti-human immunodeficiency virus type 1 (HIV-1) activities, seventeen 5,6-dihydro-indolo[1,2-a]quinoxaline derivatives (1-17) were preliminarily evaluated as HIV-1 inhibitors in vitro. Among all the derivatives, especially compounds 10 and 17 showed the most potent anti-HIV-1 activities with EC50 values of 2.42 and 3.39 μg/mL, and TI values of 63.76 and 53.60, respectively.
Keywords: 5,6-Dihydro-indolo[1,2-a]quinoxaline, Acquired immunodeficiency syndrome, Human immunodeficiency virus-1, Inhibitor, AIDS, quinoxaline, HIV-1, Syncytia Assay, MTT-based Cytotoxicity Assay, TCID50, calf serum, Anti-HIV-1 Activity Assay, HIV-1 IIIB, Reed and Muench method
Letters in Drug Design & Discovery
Title: Discovery of 5,6-Dihydro-indolo[1,2-a]quinoxaline Derivatives as New HIV-1 Inhibitors In Vitro
Volume: 9 Issue: 1
Author(s): Ling-Ling Fan, Ning Huang, Rui-Ge Yang, Shu-Zhen He, Liu-Meng Yang, Hui Xu and Yong-Tang Zheng
Affiliation:
Keywords: 5,6-Dihydro-indolo[1,2-a]quinoxaline, Acquired immunodeficiency syndrome, Human immunodeficiency virus-1, Inhibitor, AIDS, quinoxaline, HIV-1, Syncytia Assay, MTT-based Cytotoxicity Assay, TCID50, calf serum, Anti-HIV-1 Activity Assay, HIV-1 IIIB, Reed and Muench method
Abstract: In continuation of our program to find compounds with potent anti-human immunodeficiency virus type 1 (HIV-1) activities, seventeen 5,6-dihydro-indolo[1,2-a]quinoxaline derivatives (1-17) were preliminarily evaluated as HIV-1 inhibitors in vitro. Among all the derivatives, especially compounds 10 and 17 showed the most potent anti-HIV-1 activities with EC50 values of 2.42 and 3.39 μg/mL, and TI values of 63.76 and 53.60, respectively.
Export Options
About this article
Cite this article as:
Fan Ling-Ling, Huang Ning, Yang Rui-Ge, He Shu-Zhen, Yang Liu-Meng, Xu Hui and Zheng Yong-Tang, Discovery of 5,6-Dihydro-indolo[1,2-a]quinoxaline Derivatives as New HIV-1 Inhibitors In Vitro, Letters in Drug Design & Discovery 2012; 9 (1) . https://dx.doi.org/10.2174/157018012798193026
DOI https://dx.doi.org/10.2174/157018012798193026 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Expression-Based Pharmacodynamic Biomarkers: The Beginning of a New Era in Biomarker-Driven Anti-Tumor Drug Development
Current Molecular Medicine How to Generate Reliable and Predictive CoMFA Models
Current Medicinal Chemistry Arylazolylthioacetanilide. Part 11: Design, Synthesis and Biological Evaluation of 1,2,4-triazole Thioacetanilide Derivatives as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
Medicinal Chemistry Antiviral Activity of Natural and Synthetic Brassinosteroids
Current Medicinal Chemistry - Anti-Infective Agents The Mechanisms of Anticancer Agents by Genistein and Synthetic Derivatives of Isoflavone
Mini-Reviews in Medicinal Chemistry HIV-1 gp41 as a Target for Viral Entry Inhibition
Current Pharmaceutical Design Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors
Current Medicinal Chemistry Rational Design, Synthesis, Anti-HIV-1 RT and Anti-microbial Activity of Novel 2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-N-phenylpropanamide Derivatives
Anti-Infective Agents Multiple Targeting by the Antitumor Drug Tamoxifen: A Structure-Activity Study
Current Medicinal Chemistry - Anti-Cancer Agents Recent Progress in the Discovery of Non-Sarcosine Based GlyT1 Inhibitors
Current Topics in Medicinal Chemistry Synthesis and Evaluation of Compounds Containing 4-arylpiperazinyl Moieties Linked to a 2-(pyridin-3-yl)-1H-benzimidazole as p38 MAP Kinase Inhibitors
Letters in Drug Design & Discovery COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review
Current Pharmaceutical Design The Antioxidant Activity of Coumarins and Flavonoids
Mini-Reviews in Medicinal Chemistry Attacking the SARS-CoV-2 Replication Machinery with the Pathogen Box’s Molecules
Letters in Drug Design & Discovery Medicinal Chemistry of Ureido Derivatives as Anti-Infectives
Anti-Infective Agents in Medicinal Chemistry Microwave-Assisted Studies on the Reactions of the 4-Benzoyl-5-Phenyl-2,3-Dihydro-2,3-Furandione and Derivatives
Letters in Organic Chemistry Predicted SARS-CoV-2 miRNAs Associated with Epigenetic Viral Pathogenesis and the Detection of New Possible Drugs for Covid-19
Current Drug Delivery COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry SAR Studies on mGlu<sub>5</sub> Receptor Positive Allosteric Modulators (2003- 2013)
Current Topics in Medicinal Chemistry